Griffin Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$990K Buy
825
+54
+7% +$55.2K 0.1% 130
2026
Q1
$709K Sell
771
-13
-2% -$13.2K 0.08% 143
2025
Q4
$843K Hold
784
0.09% 141
2025
Q3
$598K Buy
784
+254
+48% +$189K 0.07% 145
2025
Q2
$413K Sell
530
-148
-22% -$115K 0.05% 164
2025
Q1
$560K Hold
678
0.07% 145
2024
Q4
$523K Sell
678
-276
-29% -$229K 0.06% 158
2024
Q3
$845K Hold
954
0.09% 146
2024
Q2
$864K Buy
954
+300
+46% +$240K 0.1% 138
2024
Q1
$509K Hold
654
0.06% 164
2023
Q4
$381K Buy
654
+105
+19% +$61.3K 0.05% 173
2023
Q3
$295K Buy
549
+8
+1% +$4.12K 0.04% 177
2023
Q2
$254K Sell
541
-388
-42% -$163K 0.03% 192
2023
Q1
$319K Buy
929
+192
+26% +$64.8K 0.04% 179
2022
Q4
$270K Buy
+737
New +$261K 0.04% 183
2019
Q3
Sell
-108
Closed -$12K 368
2019
Q2
$12K Buy
+108
New +$12.7K ﹤0.01% 468

Other funds holding LLY

Griffin Asset Management's LLY Position: Q2 2026 in Review

Griffin Asset Management increased its Eli Lilly (LLY) stake by 7% in Q2 2026, buying an estimated $55.2K and bringing the position to 825 shares worth $990K. The position accounts for 0.1% of the portfolio, ranked #130.

Griffin Asset Management first reported a position in LLY in Q2 2019 and has held it in 16 quarters since. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Griffin Asset Management held 825 shares of Eli Lilly worth $990K as of Q2 2026.
  • Griffin Asset Management bought 54 Eli Lilly shares in Q2 2026, an estimated $55.2K.
  • Eli Lilly made up 0.1% of Griffin Asset Management's portfolio in Q2 2026, its #130 holding.
  • Griffin Asset Management first reported a position in Eli Lilly in Q2 2019 and has held it in 16 quarters since.
  • 4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Griffin Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.